Industry
For ImmunityBio Inc [IBRX], Analyst sees a drop to $4. What next?
ImmunityBio Inc [NASDAQ: IBRX] surged by $0.2 during the normal trading session on while it closed the day at $4.78. The company report on February 5, 2024 at 9:00 AM that ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the
